Skip to search formSkip to main contentSkip to account menu

pirarubicin hydrochloride

Known as: (2"R)-4'-O-Tetrahydropyranyladriamycin Hydrochloride, 4'-O-Tetrahydropyranyl Doxorubicin HCl, THP-adriamycin Hydrochloride 
The hydrochloride salt form of pirarubicin, an analogue of the anthracycline antineoplastic antibiotic doxorubicin with antineoplastic activity… 
National Institutes of Health

Related topics

Related topics

1 relation
Pirarubicin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Application of lobaplatin in trans-catheter arterial chemoembolization for primary hepatic carcinoma.
OBJECTIVE To explore the efficiency of single application of lobaplatin in tran-scatheter arterial chemoembolization (TACE) for… 
2005
2005
Diagnosing the Location of Carcinoma in situ (CIS) of the Urinary Bladder Using Pirarubicin Hydrochloride
Introduction: No established technique for locating solitary carcinoma in situ (CIS) of the urinary bladder or CIS accompanying… 
2004
2004
Pharmacokinetics and disposition of 4′-O-tetrahydropyranyladriamycin in mice by HPLC analysis
SummaryThe plasma level of 4′-O-tetrahydropyranyladriamycin (THP) declined rapidly after IV injection to mice, with a t1/2(α) of… 
2004
2004
[A case of anaphylactic shock induced by pirarubicin hydrochloride].
A 75-year-old man was admitted to our hospital for treatment of superficial bladder tumor. Transurethral resection (TUR) was… 
Highly Cited
2000
Highly Cited
2000
Transcatheter arterial chemoembolization therapy using iodized oil for patients with unresectable hepatocellular carcinoma
The current study was conducted to evaluate retrospectively the effects of three kinds of regimens used in transcatheter arterial… 
1998
1998
Pancreatic cancer associated with granulocyte-colony stimulating factor production confirmed by immunohistochemistry.
We report an 83-year-old man with pancreatic body cancer of 4.5 cm in diameter. Peripheral leukocyte count was 15,700/microl and… 
1996
1996
Primary clinical effects of PP therapy (cisplatin and peplomycin) and TPP therapy (4′-O-tetrahydropyranyladriamycin, cisplatin and peplomycin) for oral cancer
BackgroundA comparison of chemotherapy with PP (cisplatin, CDDP; and peplomycin, PEP) and TPP (4′-O-tetrahydropyranyladriamycin… 
1992
1992
Phase II trial of 4′‐O‐tetrahydropyranyladriamycin (pirarubicin) in head and neck carcinoma
Background. 4′‐O‐tetrahydropyranyladriamycin (Pirarubicin, Meiji Seika (USA) Inc., New York, NY) may be less toxic than… 
1991
1991
[Phase II study of (2" R)-4'-O-tetrahydropyranyladriamycin (THP) in patients with advanced or recurrent gastric cancer. Clinical study group of THP for gastric cancer in Japan].
A multi-institutional collaborative phase II study of (2"R)-4-O-tetrahydropyranyladriamycin (THP) was performed by intravenous… 
1986
1986
[A randomized controlled study of (2'' R)-4'-O-tetrahydropyranyladriamycin and adriamycin in combination with cyclophosphamide and 5-fluorouracil in the treatment of advanced and recurrent breast…
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)